These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22877811)

  • 41. Optimal Medical Treatment vs. Invasive Approach in Patients with Significantly Obstructive Coronary Artery Disease and Ischemia.
    Carvajal-Juarez I; Espínola-Zavaleta N; Antonio-Villa NE; Keirns C; Alexanderson-Rosas E
    Arch Med Res; 2020 Jul; 51(5):413-418. PubMed ID: 32327292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.
    Torosoff MT; Sidhu MS; Desai KP; Fein SA; Boden WE
    J Comp Eff Res; 2015 Sep; 4(5):505-14. PubMed ID: 26387530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reexamining the Efficacy and Value of Percutaneous Coronary Intervention for Patients With Stable Ischemic Heart Disease.
    Weintraub WS; Boden WE
    JAMA Intern Med; 2016 Aug; 176(8):1190-4. PubMed ID: 27380178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions.
    Blankenship JC; Marshall JJ; Pinto DS; Lange RA; Bates ER; Holper EM; Grines CL; Chambers CE;
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):243-59. PubMed ID: 22431260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial.
    Mancini GB; Hartigan PM; Bates ER; Sedlis SP; Maron DJ; Spertus JA; Berman DS; Kostuk WJ; Shaw LJ; Weintraub WS; Teo KK; Dada M; Chaitman BR; O'Rourke RA; Boden WE;
    Circ Cardiovasc Interv; 2011 Dec; 4(6):545-52. PubMed ID: 22045968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.
    Shaw LJ; Heller GV; Casperson P; Miranda-Peats R; Slomka P; Friedman J; Hayes SW; Schwartz R; Weintraub WS; Maron DJ; Dada M; King S; Teo K; Hartigan P; Boden WE; O'Rourke RA; Berman DS;
    J Nucl Cardiol; 2006 Sep; 13(5):685-98. PubMed ID: 16945749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia.
    Gada H; Kirtane AJ; Kereiakes DJ; Bangalore S; Moses JW; Généreux P; Mehran R; Dangas GD; Leon MB; Stone GW
    Am J Cardiol; 2015 May; 115(9):1194-9. PubMed ID: 25759103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.
    Dakik HA; Kleiman NS; Farmer JA; He ZX; Wendt JA; Pratt CM; Verani MS; Mahmarian JJ
    Circulation; 1998 Nov; 98(19):2017-23. PubMed ID: 9808599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?
    Xie JX; Winchester DE; Phillips LM; Hachamovitch R; Berman DS; Blankstein R; Di Carli MF; Miller TD; Al-Mallah MH; Shaw LJ
    J Nucl Cardiol; 2017 Oct; 24(5):1610-1618. PubMed ID: 28752313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trend in percutaneous coronary intervention volume following the COURAGE and BARI-2D trials: insight from over 8.1 million percutaneous coronary interventions.
    Bangalore S; Gupta N; Généreux P; Guo Y; Pancholy S; Feit F
    Int J Cardiol; 2015 Mar; 183():6-10. PubMed ID: 25662046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease.
    Ujueta F; Weiss EN; Shah B; Sedlis SP
    Curr Cardiol Rep; 2017 Feb; 19(2):17. PubMed ID: 28213668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease.
    Weiss S; Weintraub W
    Prog Cardiovasc Dis; 2015; 58(3):299-305. PubMed ID: 26206111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
    Sedlis SP; Hartigan PM; Teo KK; Maron DJ; Spertus JA; Mancini GB; Kostuk W; Chaitman BR; Berman D; Lorin JD; Dada M; Weintraub WS; Boden WE;
    N Engl J Med; 2015 Nov; 373(20):1937-46. PubMed ID: 26559572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population.
    Chatterjee S; Fanaroff AC; Parzynski C; Curtis J; Kolansky DM; Maddox TM; Mukherjee D; Yeh RW; Giri J
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2344-2349. PubMed ID: 34736733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Stress Echocardiography in the Assessment of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Stable Coronary Heart Disease].
    Karpov AY; Elkanova MM; Shitov NV; Botvina VU; Lopukhova VV; Saidova AM
    Kardiologiia; 2017 Jul; 57(7):13-19. PubMed ID: 29041876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.